Radiobiology Practice Questions

Q: What is the threshold radiation dose for the hematological syndrome?

2 Gy. ### Explanation **Acute Radiation Syndrome (ARS)** occurs after whole-body exposure to high doses of ionizing radiation. It is categorized into three distinct sub-syndromes based on the dose received and the organ system affected. **1. Why Option A (2 Gy) is Correct:** The **Hematological (Bone Marrow) Syndrome** occurs at doses between **2 and 10 Gy**. At this threshold, the radiation destroys the highly mitotic precursor cells in the bone marrow, leading to pancytopenia (depletion of white blood cells, platelets, and red blood cells). Death, if it occurs, is usually due to infection or hemorrhage within 3–6 weeks. **2. Why the Other Options are Incorrect:** * **Option B (6 Gy):** While 6 Gy falls within the range of hematological syndrome, it is above the *threshold* (starting point). At doses above 6–10 Gy, the Gastrointestinal syndrome begins to overlap and dominate. * **Option C (15 Gy):** This dose triggers the **Gastrointestinal (GI) Syndrome** (threshold: **6–10 Gy**). It involves the destruction of intestinal crypt cells, leading to severe diarrhea, dehydration, and electrolyte imbalance. Death typically occurs within 5–10 days. * **Option D (50 Gy):** This dose triggers the **Cerebrovascular (CNS) Syndrome** (threshold: **>20–50 Gy**). It results in immediate neurological symptoms, seizures, and coma, with death occurring within 24–48 hours. **High-Yield Clinical Pearls for NEET-PG:** * **LD 50/60:** The lethal dose required to kill 50% of the population in 60 days is approximately **3–4 Gy** (without medical intervention). * **Prodromal Phase:** The initial stage of ARS characterized by nausea, vomiting, and anorexia (NVA). * **Radiosensitivity:** According to the **Law of Bergonie and Tribondeau**, cells with high mitotic activity and low differentiation (like hematopoietic stem cells) are the most radiosensitive.

Q: Which of the following is NOT a radioprotector?

BUDR. **Explanation:** In radiobiology, substances are classified based on how they modify the cellular response to ionizing radiation. The distinction between **radioprotectors** and **radiosensitizers** is a high-yield topic for NEET-PG. **Why BUDR is the correct answer:** **BUDR (5-Bromo-2'-deoxyuridine)** is a **radiosensitizer**, not a radioprotector. It is a halogenated pyrimidine analog that incorporates into the DNA of rapidly dividing cells in place of thymidine. This substitution makes the DNA chain more fragile and susceptible to radiation-induced strand breaks, thereby increasing the lethality of a given dose of radiation. **Analysis of incorrect options (Radioprotectors):** * **Amifostine (WR-2721):** This is the most potent and well-known radioprotector. It is a sulfhydryl compound that acts as a free radical scavenger. It is FDA-approved to reduce xerostomia in patients undergoing radiotherapy for head and neck cancers. * **IL-1 (Interleukin-1):** Cytokines like IL-1 act as biological response modifiers. They protect hematopoietic stem cells and promote recovery of the bone marrow after radiation exposure. * **GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor):** This is a growth factor that stimulates the proliferation of white blood cells. It is used clinically to mitigate hematologic toxicity (bone marrow syndrome) following radiation. **Clinical Pearls for NEET-PG:** * **Oxygen Effect:** Oxygen is the most potent naturally occurring radiosensitizer. * **Sulfhydryl Compounds:** Most radioprotectors work by scavenging free radicals (produced by indirect action of radiation) or by donating hydrogen atoms to repair DNA lesions. * **Radiosensitizers list:** BUDR, IUDR, Metronidazole, Misonidazole, and Cisplatin. * **Radioprotectors list:** Amifostine, Cysteine, Cysteamine, Vitamin E, and certain cytokines (IL-1, TNF-alpha).

Q: What is observed in the part of the bone which received radiotherapy?

More destruction of bone. ***More destruction of bone*** - Radiotherapy causes **radiation osteitis** and **osteoradionecrosis**, leading to progressive bone destruction and necrosis. - **Impaired vascularization** and cellular damage result in weakened bone structure and increased susceptibility to fractures. *Response to radiotherapy is good* - While radiotherapy may effectively treat tumors, the **bone tissue itself responds poorly** to radiation exposure. - **Bone cells** (osteoblasts and osteocytes) are particularly sensitive to radiation damage, leading to compromised bone integrity. *Fast healing* - Radiation actually **impairs bone healing** by damaging blood vessels and reducing cellular regeneration capacity. - **Delayed union** or **non-union** of fractures is common in irradiated bone due to compromised osteoblastic activity. *Tumor regression is not affected* - While tumor regression may occur with adequate radiation doses, this doesn't address the **direct effects on bone tissue**. - The question specifically asks about bone changes, not tumor response to radiotherapy.

Q: Which of the following statements about Linear Energy Transfer (LET) is true?

High LET radiations have a low oxygen enhancement ratio.. **Explanation:** **1. Why the Correct Answer is Right:** Linear Energy Transfer (LET) is the rate at which energy is deposited as an ionizing particle travels through matter (keV/µm). **High LET radiations** (e.g., alpha particles, neutrons) cause dense, direct ionization of DNA, leading to irreparable double-strand breaks. Because this damage is direct and physical, it does not rely on the presence of oxygen to "fix" the damage (the Oxygen Fixation Hypothesis). Therefore, High LET radiations have a **low Oxygen Enhancement Ratio (OER)**, meaning they are nearly as effective in hypoxic conditions as they are in oxygenated ones. **2. Why the Incorrect Options are Wrong:** * **Option A:** Low LET radiations (e.g., X-rays, Gamma rays) are **less lethal** per unit dose because they cause sparse ionizations and rely heavily on indirect action (free radical formation), which cells can often repair. * **Option B:** LET is a **property of the radiation** (the projectile), not the tissue. It depends on the charge and velocity of the ionizing particle. * **Option C:** LET and Relative Biological Effectiveness (RBE) are related but **not the same**. RBE is a ratio comparing the biological effect of a test radiation to a standard (250 kVp X-rays). As LET increases, RBE generally increases (up to a point of "overkill" at 100 keV/µm). **3. NEET-PG High-Yield Clinical Pearls:** * **OER Formula:** Dose required under hypoxic conditions / Dose required under aerobic conditions. * **OER Values:** For X-rays (Low LET), OER is ~2.5–3.0. For Alpha particles (High LET), OER is ~1.0. * **The "Overkill" Effect:** RBE peaks at an LET of **100 keV/µm**. Beyond this, energy is wasted because the DNA is already "over-killed," and RBE actually decreases. * **Direct vs. Indirect Action:** High LET = Direct action (dominant); Low LET = Indirect action (dominant, mediated by OH• radicals).

Q: Acute radiation hepatic damage is most marked between which time period?

40-100 days. **Explanation:** **Radiation-Induced Liver Disease (RILD)**, often referred to as radiation hepatitis, is a subacute clinical syndrome. Unlike the immediate "radiation sickness" seen in the GI tract, the liver's response to radiation is delayed due to the slow turnover rate of hepatocytes and vascular endothelial cells. 1. **Why 40–100 days is correct:** The underlying pathophysiology of acute radiation hepatic damage is **Veno-Occlusive Disease (VOD)**. Following radiotherapy, there is a progressive obstruction of the central veins of the liver lobules due to fibrin deposition and endothelial swelling. This process takes time to manifest clinically. Symptoms typically peak between **2 to 6 weeks (subacute phase)** but the most marked clinical and pathological damage is classically observed between **40 and 100 days** post-exposure. 2. **Why other options are incorrect:** * **1–7 days:** This period corresponds to the *Prodromal phase* of radiation syndrome (nausea, vomiting), not specific organ parenchymal damage. * **7–21 days:** This is the *Latent period* for the liver. While hematopoietic damage (bone marrow) manifests here, the liver remains clinically asymptomatic. * **21–40 days:** This is the early onset period. While damage begins, it has not yet reached its "most marked" or peak clinical presentation. **High-Yield Clinical Pearls for NEET-PG:** * **Pathological Hallmark:** Central venous congestion and "Veno-occlusive disease" (VOD). * **Clinical Triad:** Hepatomegaly, ascites, and elevated alkaline phosphatase (disproportionate to bilirubin). * **Tolerance Dose (TD 5/5):** The whole-liver tolerance dose is approximately **30–35 Gy**. Exceeding this significantly increases the risk of RILD. * **Radiological Sign:** On CT, acute radiation hepatitis appears as a well-defined area of low attenuation corresponding exactly to the radiation portal.

Question 1

What is the threshold radiation dose for the hematological syndrome?

Accepted Answer

2 Gy

Answer

6 Gy

Answer

15 Gy

Answer

50 Gy

Question 2

Which of the following is NOT a radioprotector?

Accepted Answer

BUDR

Answer

Amifostine

Answer

IL-1

Answer

GM-CSF

Question 3

What is observed in the part of the bone which received radiotherapy?

Accepted Answer

More destruction of bone

Answer

Response to radiotherapy is good

Answer

Fast healing

Answer

Tumor regression is not affected

Question 4

Which of the following statements about Linear Energy Transfer (LET) is true?

Accepted Answer

High LET radiations have a low oxygen enhancement ratio.

Answer

Low LET radiations are more lethal.

Answer

It is a property of the tissue.

Answer

It is the same as relative biological effectiveness.

Question 5

Acute radiation hepatic damage is most marked between which time period?

Accepted Answer

40-100 days

Answer

1-7 days

Answer

7-21 days

Answer

21-40 days

Radiobiology — MCQs

Radiobiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?